State of the art catheter interventions in adults with congenital heart disease

Expert Review of Cardiovascular Therapy

Volumn 2, Issue 5, 2004, Pages 699-711

  Holzer, Ralf ^a   Cao, Qi Ling ^a   Hijazi, Ziyad M ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Adult; Cardiac catheterization; Congenital heart disease

Indexed keywords

DIURETIC AGENT;

AORTA COARCTATION; AORTA VALVE REGURGITATION; AORTA VALVE STENOSIS; CONGENITAL HEART DISEASE; CONGENITAL HEART MALFORMATION; CORONARY ARTERY FISTULA; FONTAN PROCEDURE; HEART ATRIUM SEPTUM DEFECT; HEART CATHETERIZATION; HEART VALVE REPLACEMENT; HEART VENTRICLE SEPTUM DEFECT; HUMAN; MITRAL VALVE REGURGITATION; MITRAL VALVE STENOSIS; MUSTARD OPERATION; PATENT DUCTUS ARTERIOSUS; PULMONARY ARTERY STENOSIS; PULMONARY VALVE INSUFFICIENCY; PULMONARY VALVE STENOSIS; REVIEW;

ADULT; CORONARY ANGIOGRAPHY; ECHOCARDIOGRAPHY; HEART CATHETERIZATION; HEART DEFECTS, CONGENITAL; HUMANS; RADIOGRAPHY, INTERVENTIONAL; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 4544278204     PISSN: 14779072     EISSN: None     Source Type: Journal    
DOI: 10.1586/14779072.2.5.699     Document Type: Review

References (105)

1. Bonhoeffer P, Boudjemline Y, Qureshi SA et al. Percutaneous insertion of the pulmonary valve. J. Am. Coll. Cardiol. 39, 1664-1669 (2002).
2. Cribier A, Eltchaninoff H, Bash A et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 106, 3006-3008 (2002).
3. Cribier A, Eltchaninoff H, Tron C et al. Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end stage inoperable patients with calcific aortic stenosis. J. Am. Coll. Cardiol. 43, 698-703 (2004).
4. Hijazi ZM, Hakim F, Haweleh AA et al. Catheter closure of perimembranous ventricular septal defects using the new Amplatzer membranous VSD occluder: initial clinical experience. Catheter Cardiovasc. Interv. 56, 508-515 (2002).
5. Holzer R, Balzer D, Cao QL, Lock K, Hijazi ZM. Device closure of muscular ventricular septal defects using the Amplatzer muscular ventricular septal defect occluder: immediate and midterm results of a US registry. J. Am. Coll. Cardiol. 43, 1257-1263 (2004).
6. Steele PM, Fuster V, Cohen M, Ritter DG, McGoon DC. Isolated atrial septal defect with pulmonary vascular obstructive disease - long-term follow-up and prediction of outcome after surgical correction. Circulation 76, 1037-1042 (1987).
7. King TD, Thompson SL, Steiner C, Mills NL. Secundum atrial septal defect Nonoperative closure during cardiac catheterization. J. Am. Med. Assoc. 235, 2506-2509 (1976).
8. Fischer G, Stieh J, Uebing A, Hoffmann U, Morf G, Kramer HH. Experience with transcatheter closure of secundum atrial septal defects using the Amplatzer septal occluder: a single center study in 236 consecutive patients. Heart 89, 199-204 (2003).
9. Du ZD, Hijazi ZM, Kleinman CS, Silverman NH, Larntz K, Amplatzer I. Comparison between transcatheter and surgical closure of secundum atrial septal defect in children and adults: results of a multicenter, nonrandomized trial. J. Am. Coll. Cardiol. 39, 1836-1844 (2002).
10. Chessa M, Carminati M, Butera G et al. Early and late complications associated with transcatheter occlusion of secundum atrial septal defect. J. Am. Coll. Cardiol. 39, 1061-1065 (2002).
11. Masura J, Gavora P, Formanek A, Hijazi ZM. Transcatheter closure of secundum atrial septal defects using the new self-centering amplatzer septal occluder: initial human experience. Catheter Cardiovasc. Diagn. 42, 388-393 (1997).
12. Allen HD, Beekman RH III, Garson A Jr et al. Pediatric therapeutic cardiac catheterization: a statement for healthcare professionals from the Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 97, 609-625 (1998) (Erratum, Circulation 97[23], 2375 [1998]).
13. Du ZD, Koenig P, Cao QL, Waight D, Heitschmidt M, Hijazi ZM. Comparison of transcatheter closure of secundum atrial septal defect using the Amplatzer septal occluder associated with deficient versus sufficient rims. Am. J. Cardiol. 90, 865-869 (2002).
14. Cheatham JP, Hill SL, Chisolm JL. Initial results using the new cribriform Amplatzer septal occluder for transcatheter closure of multifenestrated atrial septal defects with septal aneurysm. Catheter Cardiovasc. Interv. 60, 126 (2003) (Abstract).
15. Dhillon R, Thanopoulos B, Tsaousis G, Triposkiadis F, Kyriakidis M, Redington A. Transcatheter closure of atrial septal defects in adults with the Amplatzer septal occluder. Heart 82(5), 559-562 (1999).
16. Ewert P, Berger F, Nagdyman N et al. Masked left ventricular restriction in elderly patients with atrial septal defects: a contraindication for closure? Catheter Cardiovasc. Interv. 52, 177-180 (2001).
17. Amin Z, Danford DA, Pedra CA. A new Amplatzer device to maintain patency of Fontan fenestrations and atrial septal defects. Catheter Cardiovasc. Interv. 57, 246-251 (2002).
18. Onorato E, Melzi G, Casilli F et al. Patent foramen ovate with paradoxical embolism: medterm results of transcatheter closure in 256 patients. J. Interv. Cardiol. 16, 43-50 (2003).
19. Zanchetta M, Rigatelli G, Onorato E. Intracardiac echocardiography and transcranial Doppler ultrasound to guide closure of patent foramen ovale. J. Invasive Cardiol. 15, 93-96 (2003).
20. Morandi E, Anzola GP, Angeli S, Melzi G, Onorato E. Transcatheter closure of patent foramen ovate: a new migraine treatment? J. Interv. Cardiol. 16, 39-42 (2003).
21. Wilmshurst PT, Nightingale S, Walsh KP, Morrison WL. Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for hemodynamic reasons. Lancet 356, 1648-1651 (2000).
22. Campbell M. Natural history of persistent ductus arteriosus. Br. Heart J. 30, 4-13 (1968).
23. Porstmann W, Wierny L, Warnke H. Closure of ductus arteriosus persistens without thoracotomy. Fortschr. Geb. Rontgenstr. Nuklearmed. 109, 133-148 (1968).
24. Godart F, Rey C, Devos P, Breviere GM, Francart C. Transcatheter occlusion of moderate to large patent arterial ducts, having a diameter above 2.5 mm, with the Amplatzer duct occluder. Comparisons with the Rashkind, buttoned devices, and coils in 116 consecutive patients. Cardiol. Young 13, 413-419 (2003).
25. Faella HJ, Hijazi ZM. Closure of the patent ductus arteriosus with the amplatzer persistent arterial duct device: immediate results of the international clinical trial. Catheter Cardiovasc. Interv. 51, 50-54 (2000).
26. Hong TE, Hellenbrand WE, Hijazi ZM, Amplatzer I. Transcatheter closure of patent ductus arteriosus in adults using the Amplatzer duct occluder: initial results and follow-up. Indian Heart J. 54, 384-389 (2002).
27. Ebeid MR, Gaymes CH, Smith JC, Braden DS, Joransen JA. Gianturco-Grifka vascular occlusion device for closure of patent ductus arteriosus. Am. J. Cardiol. 87, 657-660 (2001).
28. Ewert P, Kretschmar O, Nuernberg JH, Nagdyman N, Lange PE. First closure of a large patent ductus arteriosus in an infant with an angulated nitinol plug. Catheter Cardiavasc. Interv. 57, 88-91 (2002).
29. Hijazi ZM. A new device for percutaneous closure of aortopulmonary collaterals. Catheter Cardiovasc. Interv. (2004) (In press).
30. Crenshaw BS, Granger CB, Birnbaum Y et al. Risk factors, angiographic patterns, and outcomes in patients with ventricular septal defect complicating acute myocardial infarction. GUSTO-I (Global Utilization of Streptokinase and TPA for Occluded coronary arteries) trial investigators. Circulation 101, 27-32 (2000).
31. Menon V, Webb JG, Hillis LD et al. Outcome and profile of ventricular septal rupture with cardiogenic shock after myocardial infarction: a report from the SHOCK trial registry: SHould we emergently revascularize Occluded Coronaries in cardiogenic shocK? J. Am. Coll. Cardiol. 36, 1110-1116 (2000).
32. Holzer RJ, Balzer D, Amin Z et al. Transcatheter closure of post infarction ventricular septal defects using the new amplatzer muscular VSD occluder: results of a US Registry. Catheter Cardiovasc. Interv. 61, 196-201 (2004).
33. Pesenti-Rossi D, Godart F, Dubar A, Rey C. Transcatheter closure of traumatic ventricular septal defect: an alternative to surgery. Chest 123, 2144-2145 (2003).
34. Bauriedel G, Redel DA, Schmitz C, Welz A, Schild HH, Luderitz B. Transcatheter closure of a posttraumatic ventricular septal defect with an Amplatzer occluder device. Catheter Cardiovasc. Interv. 53, 508-512 (2001).
35. Holzer RJ, Hijazi ZM. Device closure of perimembranous ventricular septal defects using the Amplatzer membranous VSD occluder in two patients with prosthetic aortic valve. Catheter Cardiovasc. Interv. 62(2), 276-280 (2004).
36. McDaniel NL, Gutgesell HP. Ventricular septal defects. In: Heart Disease in Infants, Children and Adolescents. Allen HD, Gutgesell HP, Clark EB, Driscoll DJ (Eds), Lippincott Williams & Wilkins, PA, USA, 636-651 (2001).
37. Kidd L, Driscoll DJ, Gersony WM et al. Second natural history study of congenital heart defects. Results of treatment of patients with ventricular septal defects. Circulation 87, I38-I51 (1993).
38. Serraf A, Lacour-Gayet F, Bruniaux J et al. Surgical management of isolated multiple ventricular septal defects. Logical approach in 130 cases. J. Thorac. Cardiovasc. Surg. 103, 437-442 (1992).
39. Seddio F, Reddy VM, McElhinney DB, Tworetzky W, Silverman NH, Hanley FL. Multiple ventricular septal defects: how and when should they be repaired? J. Thorac. Cardiovasc. Surg. 117, 134-139 (1999).
40. Lock JE, Block PC, McKay RG, Baim DS, Keane JF. Transcatheter closure of ventricular septal defects. Circulation 78, 361-368 (1988).
41. Rigby ML, Redington AN. Primary transcatheter umbrella closure of perimembranous ventricular septal defect. Br. Heart J. 72, 368-371 (1994).
42. Lavoie J, Javorski JJ, Castaneda AR, Mihalka JP, Rosenfeld HM, Sanders SP. Intraoperative migration of a clamshell device. J. Cardiothorac. Vasc. Anesth. 9, 562-564 (1995).
43. Luciani GB, Starnes VA. Clamshell for pulmonary atresia, ventricular septal defect, and aortopulmonary collaterals. Ann. Thorac. Surg. 62, 1247-1248 (1996).
44. Laussen PC, Hansen DD, Perry SB et al. Transcatheter closure of ventricular septal defects: hemodynamic instability and anesthetic management. Anesth. Analg. 80, 1076-1082 (1995).
45. Landzberg MJ, Lock JE. Transcatheter management of ventricular septal rupture after myocardial infarction. Semin. Thorac. Cardiovasc. Surg. 10, 128-132 (1998).
46. Pienvichit P, Piemonte TC. Percutaneous closure of postmyocardial infarction ventricular septal defect with the CardioSEAL septal occluder implant. Catheter Cardiovasc. Interv. 54, 490-494 (2001).
47. Sideris EB, Walsh KP, Haddad JL, Chen CR, Ren SG, Kulkarni H. Occlusion of congenital ventricular septal defects by the buttoned device. Buttoned device clinical trials international register. Heart 77, 276-279 (1997).
48. Kalra GS, Verma PK, Singh S, Arora R. Transcatheter closure of ventricular septal defect using detachable steel coil. Heart 82, 395-396 (1999).
49. Latiff HA, Alwi M, Kandhavel G, Samion H, Zambahari R. Transcatheter closure of multiple muscular ventricular septal defects using Gianturco coils. Ann. Thorac. Surg. 68, 1400-1401 (1999).
50. Chaudhari M, Chessa M, Stumper O, De Giovanni JV. Transcatheter coil closure of muscular ventricular septal defects. J. Interv. Cardiol. 14, 165-168 (2001).
51. Arora R, Trehan V, Kumar A, Kalra GS, Nigam M. Transcatheter closure of congenital ventricular septal defects: experience with various devices. J. Interv. Cardiol. 16, 83-91 (2003).
52. Thanopoulos BD, Tsaousis GS, Konstadopoulou GN, Zarayelyan AG. Transcatheter closure of muscular ventricular septal defects with the amplatzer ventricular septal defect occluder: initial clinical applications in children. J. Am. Coll. Cardiol. 33, 1395-1399 (1999).
53. Hijazi ZM, Hakim F, Al Fadley F, Abdelhamid J, Cao QL. Transcatheter closure of single muscular ventricular septal defects using the amplatzer muscular VSD occluder: initial results and technical considerations. Catheter Cardiovasc. Interv. 49, 167-172 (2000).
54. Lee EM, Roberts DH, Walsh KP. Transcatheter closure of a residual postmyocardial infarction ventricular septal defect with the Amplatzer septal occluder. Heart 80, 522-524 (1998).
55. Pesonen E, Thilen U, Sandstrom S et al. Transcatheter closure of postinfarction ventricular septal defect with the Amplatzer septal occluder device. Scand. Cardiovasc. J. 34, 446-448 (2000).
56. Mullasari AS, Umesan CV, Krishnan U, Srinivasan S, Ravikumar M, Raghuraman H. Transcatheter closure of postmyocardial infarction ventricular septal defect with Amplatzer septal occluder. Catheter Cardiovasc. Interv. 54, 484-487 (2001).
57. Rodes J, Piechaud JF, Ouaknine R et al. Transcatheter closure of apical ventricular muscular septal defect combined with arterial switch operation in a newborn infant. Catheter Cardiovasc. Interv. 49, 173-176 (2000).
58. Szkutnik M, Bialkowski J, Kusa J et al. Postinfarction ventricular septal defect closure with Amplatzer occluders. Eur. J. Cardiothorac. Surg. 23, 323-327 (2003).
59. Chessa M, Carminati M, Cao QL et al. Thanscatheter closure of congenital and acquired muscular ventricular septal defects using the Amplatzer device. J. Invasive Cardiol. 14, 322-327 (2002).
60. Amin Z, Gu Y, Berry JM et al. New device for closure of muscular ventricular septal defects in a canine model. Circulation 100, 320-328 (1999).
61. Tofeig M, Patel RG, Walsh KP. Transcatheter closure of a midmuscular ventricular septal defect with an amplatzer VSD occluder device. Heart 81, 438-440 (1999).
62. Butera G, Carminati M, De Luca F, Chessa M, Bini MR. Transcatheter treatment of muscular ventricular septal defect and pulmonary valvar stenosis in an infant. Catheter Cardiovasc. Interv. 55, 212-216 (2002).
63. Fabrega SJ, Rodes-Cabau J, Piechaud JF et al. Percutaneous closure of a midmuscular residual ventricular septal defect using the Amplatzer™ device. Ann. Esp. Pediatr. 57, 66-69 (2002).
64. Waight DJ, Bacha EA, Kahana M, Cao QL, Heitschmidt M, Hijazi ZM. Catheter therapy of Swiss cheese ventricular septal defects using the Amplatzer muscular VSD occluder. Catheter Cardiovasc. Interv. 55, 355-361 (2002).
65. Gupta M, Juneja R, Saxena A. Simultaneous device closure of muscular ventricular septal defect and pulmonary valve balloon dilatation. Catheter Cardiovasc. Interv. 58, 545-547 (2003).
66. Bass JL, Kalra GS, Arora R et al. Initial human experience with the Amplatzer perimembranous ventricular septal occluder device. Catheter Cardiovasc. Interv. 58, 238-245 (2003).
67. Gu X, Han YM, Titus JL et al. Transcatheter closure of membranous ventricular septal defects with a new nitinol prosthesis in a natural swine model. Catheter Cardiovasc Interv. 50, 502-509 (2000).
68. Hijazi ZM, Hakim F, Haweleh AA et al. Catheter closure of perimembranous ventricular septal defects using the new Amplatzer membranous VSD occluder: initial clinical experience. Catheter Cardiovasc. Interv. 56, 508-515 (2002).
69. Thanopoulos BD, Tsaousis GS, Karanasios E, Eleftherakis NG, Paphitis C. Transcatheter closure of perimembranous ventricular septal defects with the Amplatzer asymmetric ventricular septal defect occludcr: preliminary experience in children. Heart 89, 918-922 (2003).
70. Campbell M. Natural history of persistent ductus arteriosus. Br. Heart J. 30, 4-13 (1968).
71. Ovaert C, Benson LN, Nykanen D, Freedom RM. Transcatheter treatment of coarctation of the aorta: a review. Pediatr. Cardiol. 19, 27-44 (1998).
72. Fawzy ME, Sivanandam V, Galal O et al. 1- to 10-year follow-up results of balloon angioplasty of native coarctation of the aorta in adolescents and adults. J. Am. Coll. Cardiol. 30, 1542-1546 (1997).
73. Hamdan MA, Maheshwari S, Fahey JT, Hellenbrand WE. Endovascular stents for coarctation of the aorta: initial results and intermediate-term follow-up. J. Am. Coll. Cardiol. 38, 1518-1523 (2001).
74. Thanopoulos BD, Hadjinikolaou L, Konstadopoulou GN, Tsaousis GS, Triposkiadis F, Spirou P. Stent treatment for coarctation of the aorta: intermediate term follow-up and technical considerations. Heart 84, 65-70 (2000).
75. McCrindle BW, Jones TK, Morrow WR et al. Acute results of balloon angioplasty of native coarctation versus recurrent aortic obstruction are equivalent. Valvuloplasty and Angioplasty of Congenital Anomalies (VACA) registry investigators. J. Am. Coll. Cardiol. 28, 1810-1817 (1996).
76. Anjos R, Qureshi SA, Rosenthal E et al. Determinants of hemodynamic results of balloon dilation of aortic recoarctation. Am. J. Cardiol. 69, 665-671 (1992).
77. Zabal C, Attie F, Rosas M, Buendia-Hernandez A, Garcia-Montes JA. The adult patient with native coarctation of the aorta: balloon angioplasty or primary stenting? Heart 89(1), 77-83 (2003).
78. Forbes T, Matisoff D, Dysart J, Aggarwal S. Treatment of coexistent coarctation and aneurysm of the aorta with covered stent in a pediatric patient. Pediatr. Cardiol. 24, 289-291 (2003).
79. Cheatham JP. Stenting of coarctation of the aorta. Catheter Cardiovasc. Interv. 54, 112-125 (2001).
80. Harrison DA, McLaughlin PR, Lazzam C, Connelly M, Benson LN. Endovascular stents in the management of coarctation of the aorta in tile adolescent and adult: 1 year follow-up. Heart 85, 561-566 (2001).
81. Shaddy RE, Boucek MM, Sturtevant JE et al. Comparison of angioplasty and surgery for unoperated coarctation of the aorta. Circulation 87, 793-799 (1993).
82. Kirklin JW, Barratt-Boyes BG. Coarctation of the aorta and interrupted aortic arch. In: Cardiac Surgery. Kirklin JW, Barratt-Boyes BG (Eds), Churchill-Livingstone, NY, USA (1992).
83. Rosenthal E. Stent implantation for aortic coarctation: the treatment of choice in adults? J. Am. Coll. Cardiol. 38, 1524-1527 (2001).
84. ACC/AHA guidelines for the management of patients with valvular heart disease. A report of the American College of Cardiology/American Heart Association. Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease). J. Am. Coll. Cardiol. 32, 1486-1588 (1998).
85. Moore P, Egito E, Mowrey H, Perry SB, Lock JE, Keane JF. Midterm results of balloon dilation of congenital aortic stenosis: predictors of success. J. Am. Coll. Cardiol. 27, 1257-1263 (1996).
86. Daehnert I, Rotzsch C. Rapid right ventricular pacing as an alternative to adenosine in interventions for congenital heart disease. Catheter Cardiovasc. Interv. 60, 133 (2003) (Abstract).
87. Kan JS, White RI Jr, Mitchell SE, Gardner TJ. Percutancous balloon valvuloplasty: a new method for treating congenital pulmonary valve stenosis. N. Engl. J. Med. 307, 540-542 (1982).
88. Boudjemline Y, Agnoletti G, Bonnet D, Sidi D, Bonhoeffer P. Percutaneous pulmonary valve replacement in a large right ventricular outflow tract: an experimental study. J. Am. Coll. Cardiol. 43, 1082-1087 (2004).
89. Gentles TL, Lock JE, Perry SB. High pressure balloon angioplasty for branch pulmonary artery stenosis: early experience. J. Am. Coll. Cardiol. 22, 867-872 (1993).
90. Shaffer KM, Mullins CE, Grifka RG et al. Intravascular stents in congenital heart disease: short- and long-term results from a large single-center experience. J. Am. Coll. Cardiol. 31, 661-667 (1998).
91. Fogelman R, Nykanen D, Smallhorn JF, McCrindle BW, Freedom RM, Benson LN. Endovascular stents in the pulmonary circulation. Clinical impact on management and medium-term follow-up. Circulation 92, 881-885 (1995).
92. Baker CM, McGowan FX Jr, Keane JF, Lock JE. Pulmonary artery trauma due to balloon dilation: recognition, avoidance and management. J. Am. Coll. Cardiol. 36, 1684-1690 (2000).
93. Trivedi KR, Benson LN. Interventional strategies in the management of peripheral pulmonary artery stenosis. J. Interv. Cardiol. 16, 171-188 (2003).
94. Block PC. Percutaneous mitral valve repair for mitral regurgitation. J. Interv. Cardiol. 16, 93-96 (2003).
95. Lock JE, Khalilullah M, Shrivastava S, Bahl V, Keane JF. Percutaneous catheter commissurotomy in rheumatic mitral stenosis. N. Engl. J. Med. 313, 1515-1518 (1985).
96. Reyes VP, Raju BS, Wynne J et al. Percutaneous balloon valvuloplasty compared with open surgical commissurotomy for mitral stenosis. N. Engl. J. Med. 331, 961-967 (1994).
97. Boudjemline Y, Abdel-Massih T, Bonhoeffer P et al. Percutaneous closure of a paravalvular mitral regurgitation with Amplatzer and coil prostheses. Arch. Malad. Coeur Vaiss. 95, 483-486 (2002).
98. Hijazi ZM. Transcatheter management of paravalvular mitral leaks: far from ideal. Catheter Cardiovasc. Interv. 61, 552-553 (2004).
99. Urrutia-S CO, Falaschi G, Ott DA, Cooley DA. Surgical management of 56 patients with congenital coronary artery fistulas. Ann. Thorac. Surg. 35, 300-307 (1983).
100. Liberthson RR, Sagar K, Berkoben JP, Weintraub RM, Levine FH. Congenital coronary arteriovenous fistula. Report of 13 patients, review of the literature and delineation of management. Circulation 59, 849-854 (1979).
101. Morgan JR, Forker AD, O'Sullivan MJ Jr, Fosburg RG. Coronary arterial fistulas: seven cases with unusual features. Am. J. Cardiol. 30, 432-436 (1972).
102. Qureshi SA, Tynan M. Catheter closure of coronary artery fistulas. J. Interv. Cardiol. 14, 299-307 (2001).
103. Hakim F, Madani A, Goussous Y, Cao QL, Hijazi ZM. Transcatheter closure of a large coronary arteriovenous fistula using the new Amplatzer duct occluder. Cathet. Cardiovasc. Diagn. 45, 155-157 (1998).
104. Okubo M, Nykanen D, Benson LN. Outcomes of transcatheter embolization in the treatment of coronary artery fistulas. Catheter Cardiovasc. Interv. 52, 510-517 (2001).
105. Pedra CA, Pihkala J, Nykanen DG, Benson LN. Antegrade transcatheter closure of coronary artery fistulas using vascular occlusion devices. Heart 83, 94-96 (2000).